Story
PayPal Surges on Takeover Report; Micron, Progressive Among Major Decliners
Summary
PayPal shares rallied nearly 17% following a report of a $53 billion takeover bid, while Aehr Test Systems surged on strong guidance. On the downside, Micron Technology and The Progressive Corp. saw significant declines in Wednesday's trading.
U.S. equity markets saw significant divergence among individual stocks on Wednesday, with company-specific news driving substantial volatility across various sectors. Takeover speculation, corporate guidance, and regulatory updates were key catalysts, creating standout winners and losers.
Gainers Surge on Specific News
Several companies experienced double-digit percentage gains fueled by distinct positive developments. The most notable movers included:
- PayPal Holdings (PYPL): The large-cap payments firm was the day's standout, surging 16.86% following a report that Stripe and Advent International had made a $53 billion takeover bid for the company.
- Aehr Test Systems (AEHR): Shares of the semiconductor test equipment maker skyrocketed 31.9%. The rally was attributed to the company issuing strong forward guidance and announcing record bookings.
- Lucid Group (LCID): The electric vehicle manufacturer's stock jumped 15.8% after the company publicly denied bankruptcy rumors and reassured investors that its liquidity was sufficient.
Among mega-cap stocks, Oracle Corp. (ORCL) and Amazon.com Inc. (AMZN) also posted solid gains, rising 3.49% and 2.97%, respectively.
AdDecliners Face Headwinds
On the other side of the ledger, several stocks faced significant selling pressure. Mega-cap chipmaker Micron Technology (MU) was a notable loser, with its shares falling 6.36%.
Insurance giant The Progressive Corp. (PGR) saw its stock decline by 7.82%. The drop occurred even as the company reported that its second-quarter net income had increased by 4%.
In a potential "sell-the-news" reaction, shares of Celcuity (CELC) fell 16.21%. The decline came despite the positive news that the U.S. Food and Drug Administration (FDA) had approved the company's breast cancer treatment, Revtorpyk.
Read next
More on Stocks
Apple's Tim Cook Views Australia's Social Media Curbs as 'World-Leading,' PM Albanese Says
Apple Executive Chair Tim Cook praised Australia's pioneering online safety measures as "world-leading," according to Prime Minister Anthony Albanese following a meeting at the tech giant's California headquarters.
Venezuela's Interim Government Signs Energy MOU with TotalEnergies
Venezuela's interim government signed a memorandum of understanding with French energy major TotalEnergies, the latest in a series of deals aimed at attracting foreign investment back into the nation's vast oil sector.
Huawei Unveils Advanced Power and Cooling Solutions for AI Data Centers
Huawei has launched a new suite of energy infrastructure and thermal management products for AI data centers, signaling a strategic shift towards integrated power storage and intelligent liquid cooling systems to meet the demands of high-density computing.
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.